252 related articles for article (PubMed ID: 27738062)
21. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
[TBL] [Abstract][Full Text] [Related]
22. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
[TBL] [Abstract][Full Text] [Related]
23. Cardiac resynchronization therapy is associated with a reduction in ICD therapies as it improves ventricular function.
Galve E; Oristrell G; Acosta G; Ribera-Solé A; Moya-Mitjans À; Ferreira-González I; Pérez-Rodon J; García-Dorado D
Clin Cardiol; 2018 Jun; 41(6):803-808. PubMed ID: 29604094
[TBL] [Abstract][Full Text] [Related]
24. Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging.
Olimulder MA; Kraaier K; Galjee MA; Scholten MF; van Es J; Wagenaar LJ; van der Palen J; von Birgelen C
Int J Cardiovasc Imaging; 2013 Jan; 29(1):169-76. PubMed ID: 22684301
[TBL] [Abstract][Full Text] [Related]
25. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
[TBL] [Abstract][Full Text] [Related]
26. Increased risk of ventricular arrhythmias in survivors of out-of-hospital cardiac arrest with chronic total coronary occlusion.
Yap SC; Sakhi R; Theuns DAMJ; Yasar YE; Bhagwandien RE; Diletti R; Zijlstra F; Szili-Torok T
Heart Rhythm; 2018 Jan; 15(1):124-129. PubMed ID: 28917556
[TBL] [Abstract][Full Text] [Related]
27. Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network.
Greenlee RT; Go AS; Peterson PN; Cassidy-Bushrow AE; Gaber C; Garcia-Montilla R; Glenn KA; Gupta N; Gurwitz JH; Hammill SC; Hayes JJ; Kadish A; Magid DJ; McManus DD; Multerer D; Powers JD; Reifler LM; Reynolds K; Schuger C; Sharma PP; Smith DH; Suits M; Sung SH; Varosy PD; Vidaillet HJ; Masoudi FA
J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29581222
[TBL] [Abstract][Full Text] [Related]
28. Association of cardiovascular magnetic resonance-derived circumferential strain parameters with the risk of ventricular arrhythmia and all-cause mortality in patients with prior myocardial infarction and primary prevention implantable cardioverter defibrillator.
Paiman EHM; Androulakis AFA; Shahzad R; Tao Q; Zeppenfeld K; Lamb HJ; van der Geest RJ
J Cardiovasc Magn Reson; 2019 May; 21(1):28. PubMed ID: 31096987
[TBL] [Abstract][Full Text] [Related]
29. Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.
Elming MB; Nielsen JC; Haarbo J; Videbæk L; Korup E; Signorovitch J; Olesen LL; Hildebrandt P; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Videbæk R; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Thune JJ
Circulation; 2017 Nov; 136(19):1772-1780. PubMed ID: 28877914
[TBL] [Abstract][Full Text] [Related]
30. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
31. Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy.
Rayatzadeh H; Tan A; Chan RH; Patel SJ; Hauser TH; Ngo L; Shaw JL; Hong SN; Zimetbaum P; Buxton AE; Josephson ME; Manning WJ; Nezafat R
J Cardiovasc Magn Reson; 2013 Apr; 15(1):31. PubMed ID: 23574733
[TBL] [Abstract][Full Text] [Related]
32. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
[TBL] [Abstract][Full Text] [Related]
33. When to consider an implantable cardioverter defibrillator following myocardial infarction?
Szwejkowski BR; Wright GA; Connelly DT; Gardner RS
Heart; 2015 Dec; 101(24):1996-2000. PubMed ID: 26526420
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation.
Algalarrondo V; Perault R; Bories MC; Narayanan K; Garcia R; Combes N; Perier MC; Defaye P; Sadoul N; Gras D; Klug D; Bordachar P; Fauchier L; Deharo JC; Leclercq C; Boveda S; Marijon E; Babuty D;
Arch Cardiovasc Dis; 2018 Dec; 111(12):758-765. PubMed ID: 30078651
[TBL] [Abstract][Full Text] [Related]
35. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
[TBL] [Abstract][Full Text] [Related]
36. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
Herman D; Stros P; Curila K; Kebza V; Osmancik P
Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
[TBL] [Abstract][Full Text] [Related]
37. Heart rate turbulence predicts ICD-resistant mortality in ischaemic heart disease.
Marynissen T; Floré V; Heidbuchel H; Nuyens D; Ector J; Willems R
Europace; 2014 Jul; 16(7):1069-77. PubMed ID: 24196450
[TBL] [Abstract][Full Text] [Related]
38. Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. "Routine Practice" data from the SEARCH MI registry.
Boriani G; Botto G; Lunati M; Proclemer A; Schmidt B; Erdogan A; Rauhe W; Biffi M; Santi E; Becker D; Messier M; Santini M
BMC Cardiovasc Disord; 2012 Sep; 12():72. PubMed ID: 22966862
[TBL] [Abstract][Full Text] [Related]
39. Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
Antonini L; Pasceri V; Mollica C; Ficili S; Poti G; Aquilani S; Santini M; La Rocca S
J Cardiovasc Med (Hagerstown); 2011 May; 12(5):334-9. PubMed ID: 21487343
[TBL] [Abstract][Full Text] [Related]
40. Left ventricular dimensions predict risk of appropriate shocks but not mortality in cardiac resynchronization therapy-defibrillator recipients with left bundle-branch block and non-ischemic cardiomyopathy.
Adelstein EC; Schwartzman D; Jain S; Bazaz R; Wang NC; Saba S
Europace; 2017 Oct; 19(10):1689-1694. PubMed ID: 27856539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
